Dr. Michael A Borofsky , MD
Specialist • Wyomissing, PA
2760 Century Blvd
Wyomissing, PA 196103359
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 24, 2005; this date does not establish years in practice.
-
Published CMS data list 322,324 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J3262 — Injection, tocilizumab, 1 mg: 168,239 service units.
- J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered): 88,400 service units.
- J0897 — Injection, denosumab, 1 mg: 24,367 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 60 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,168 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Methotrexate (Methotrexate Sodium) — 407 prescription fills, including refills.
- Tramadol Hcl — 364 prescription fills, including refills.
- Hydroxychloroquine Sulfate — 322 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 41 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: 404. Middle half: 130 to 1,162.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 199,158 in 2020 to 322,324 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2760 Century Blvd
Wyomissing, PA 196103359
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 3 distinct group names: Arthritis And Osteoporosis Center, Inc.; H2 Rehabilitation Extension Services Llc; Phoenix Rehabilitation And Health Services Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of Pittsburgh School Of Medicine
1984
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
763 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $3,002,509 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $2,390,180 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
5,628 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$838,396 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,994.20 across 91 records.
By nature of payment
- Food and Beverage: $1,908.25 across 89 records.
- Education: $85.95 across 2 records.
Reporting-company totals (3 largest of 14)
- Amgen Inc.: $563.34 across 23 records.
- ABBVIE INC.: $263.03 across 17 records.
- Novartis Pharmaceuticals Corporation: $236.43 across 14 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
42 years (graduated 1984)
CMS Doctors and Clinicians data list 1984 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Borofsky has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Borofsky as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Wyomissing and Pennsylvania
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: 404. Middle half: 130 to 1,162.
Too few clinicians listed under Specialist in Wyomissing have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: $33,966. Middle half: $12,327 to $84,428.
Too few clinicians listed under Specialist in Wyomissing have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: $25,289. Middle half: $9,232 to $62,670.
Too few clinicians listed under Specialist in Wyomissing have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Specialist in Pennsylvania (2024, 423 clinicians with data). Median for this group: 740. Middle half: 130 to 2,767.
Too few clinicians listed under Specialist in Wyomissing have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Specialist in Pennsylvania (2024, 423 clinicians with data). Median for this group: $67,486. Middle half: $3,569 to $475,033.
Too few clinicians listed under Specialist in Wyomissing have Medicare Part D data for 2024 to compare.
9 active clinicians are listed under Specialist with a practice address in Wyomissing, PA (2,030 in Pennsylvania).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 62% from 199,158 in 2020 to 322,324 in 2024.
- 2020: 199,158
- 2021: 183,450
- 2022: 222,627
- 2023: 234,016
- 2024: 322,324
-
Medicare-allowed amount
Medicare-allowed amount increased 29% from $2,333,053 in 2020 to $3,002,509 in 2024.
- 2020: $2,333,053
- 2021: $2,135,415
- 2022: $2,184,583
- 2023: $2,274,872
- 2024: $3,002,509
-
Paid by Medicare
Paid by Medicare increased 29% from $1,851,970 in 2020 to $2,390,180 in 2024.
- 2020: $1,851,970
- 2021: $1,702,466
- 2022: $1,735,982
- 2023: $1,806,776
- 2024: $2,390,180
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 2,925 in 2020 and 3,168 in 2024.
- 2020: 2,925
- 2021: 2,962
- 2022: 2,775
- 2023: 2,929
- 2024: 3,168
-
30-day fills
30-day fills increased 22% from 4,617 in 2020 to 5,628 in 2024.
- 2020: 4,617
- 2021: 4,861
- 2022: 4,789
- 2023: 5,008
- 2024: 5,628
-
Part D drug cost
Part D drug cost stayed about the same: $821,673 in 2020 and $838,396 in 2024.
- 2020: $821,673
- 2021: $901,654
- 2022: $833,758
- 2023: $897,911
- 2024: $838,396
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $254.98 in 2021 to $1,994.20 in 2025.
- 2021: $254.98
- 2022: $440.89
- 2023: $1,238.50
- 2024: $1,565.01
- 2025: $1,994.20
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 91 records totaling $1,994.20.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $125.00 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $77.99 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $32.90 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $31.92 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $31.67 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
SAPHNELO | General | $31.19 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $30.78 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $30.09 |
| KYOWA KIRIN, INC. |
Food and Beverage
In-kind items and services
|
CRYSVITA | General | $29.35 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $29.14 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
— | General | $28.00 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $27.55 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
UPLIZNA | General | $27.53 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
BENLYSTA | General | $27.10 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
SAPHNELO | General | $26.40 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $26.39 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $26.36 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $26.36 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Gazyva | General | $26.24 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
UPLIZNA | General | $26.14 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $25.99 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
— | General | $25.87 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $25.49 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $25.49 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
BENLYSTA | General | $25.35 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J3262
Injection, tocilizumab, 1 mg
|
168,239 | 56 | $7.82 | $5.92 |
|
J0717
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
|
88,400 | 41 | $13.50 | $4.55 |
|
J0897
Injection, denosumab, 1 mg
|
24,367 | 285 | $31.08 | $25.48 |
|
J3111
Injection, romosozumab-aqqg, 1 mg
|
13,230 | 24 | $15.05 | $10.71 |
|
J1602
Injection, golimumab, 1 mg, for intravenous use
|
6,250 | 14 | $41.05 | $10.73 |
|
J0129
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
|
6,025 | 23 | $82.59 | $42.62 |
|
J1745
Injection, infliximab, excludes biosimilar, 10 mg
|
5,150 | 22 | $95.24 | $31.40 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
1,861 | 195 | $3.50 | $0.98 |
|
J2919
Injection, methylprednisolone sodium succinate, 5 mg
|
1,395 | 11 | $0.15 | $0.15 |
|
96372
Injection of drug or substance under skin or into muscle
|
963 | 332 | $50.00 | $13.99 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
956 | 435 | $140.00 | $124.89 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
444 | 291 | $25.00 | $16.27 |
|
86235
Measurement of antibody for assessment of autoimmune disorder, any method
|
399 | 57 | $46.00 | $17.57 |
|
36415
Insertion of needle into vein for collection of blood sample
|
382 | 243 | $10.00 | $8.56 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
344 | 97 | $135.00 | $58.56 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
298 | 226 | $110.00 | $88.20 |
|
20611
Aspiration and/or injection of fluid large joint using ultrasound guidance
|
187 | 107 | $190.48 | $118.47 |
|
86146
Beta 2 glycoprotein 1 antibody (autoantibody) measurement
|
172 | 57 | $55.00 | $24.94 |
|
86147
Cardiolipin antibody (tissue antibody) measurement
|
171 | 56 | $70.00 | $24.94 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
165 | 69 | $290.00 | $122.79 |
|
83970
Parathormone (parathyroid hormone) level
|
156 | 142 | $75.00 | $39.98 |
|
82306
Vitamin d-3 level
|
148 | 140 | $100.00 | $28.81 |
|
82040
Albumin (protein) level
|
143 | 119 | $17.00 | $4.85 |
|
82565
Blood creatinine level
|
142 | 116 | $17.50 | $5.02 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
142 | 112 | $200.00 | $175.10 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Methotrexate | Methotrexate Sodium | 407 | 29,557 | $12,652.24 | 112 |
| Tramadol Hcl | Tramadol Hcl | 364 | 10,822 | $4,495.05 | 85 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 322 | 16,617 | $12,717.58 | 74 |
| Prednisone | Prednisone | 260 | 14,203 | $2,376.13 | 72 |
| Gabapentin | Gabapentin | 213 | 12,862 | $5,354.95 | 64 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 179 | 5,620 | $6,348.83 | 36 |
| Allopurinol | Allopurinol | 123 | 9,783 | $1,270.67 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 112 | 4,686 | $1,510.11 | 25 |
| Leflunomide | Leflunomide | 110 | 7,840 | $6,019.72 | 37 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 93 | 3,498 | $2,786.95 | 21 |
| Methylprednisolone | Methylprednisolone | 86 | 917 | $654.86 | 69 |
| Duloxetine Hcl | Duloxetine Hcl | 75 | 5,455 | $1,774.97 | 22 |
| Azathioprine | Azathioprine | 67 | 3,870 | $5,537.43 | 14 |
| Alendronate Sodium | Alendronate Sodium | 64 | 4,178 | $436.93 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 62 | 1,843 | $1,237.37 | 11 |
| Humira(Cf) Pen | Adalimumab | 47 | 1,596 | $448,857.10 | — |
| Meloxicam | Meloxicam | 46 | 2,880 | $103.04 | 16 |
| Folic Acid | Folic Acid | 45 | 3,330 | $314.75 | 11 |
| Celecoxib | Celecoxib | 45 | 3,630 | $2,346.67 | 18 |
| Morphine Sulfate Er | Morphine Sulfate | 40 | 1,200 | $1,347.53 | — |
| Hydrochlorothiazide | Hydrochlorothiazide | 35 | 2,343 | $117.73 | — |
| Xeljanz Xr | Tofacitinib Citrate | 32 | 960 | $181,348.91 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 1,470 | $521.67 | — |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | 676 | $432.25 | — |
| Pregabalin | Pregabalin | 26 | 1,437 | $789.70 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - RHEUMATOLOGY
I20101203000535
PA
8123236700
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Arthritis And Osteoporosis Center, Inc.
2760 Century Blvd, Wyomissing, PA 196103359
Phone: 6103754251
Phoenix Rehabilitation And Health Services Inc
2000 Westinghouse Dr, Cranberry Twp, PA 160665238
H2 Rehabilitation Extension Services Llc
137 Montgomery Ave, Boyertown, PA 195121300
Phone: 4846583150
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Rheumatology
Physician Assistant (Certified)
Nurse Practitioner
MSMSNCRNP
Specialist
Doctor of Osteopathic Medicine (D.O.)
Specialist
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Specialist
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated June 24, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Specialists in Wyomissing
- Dr. Stanley Grabias, MD
- Dr. Peter Nicholas, MD
- Dr. Saurin Mehta, MD
- Dr. Larry Rotenberg, MD
- Dr. Robert Griffin, DO
Mailing Address
2760 Century Blvd
Wyomissing, PA 196103359
Phone: 6103754251